Exciting news from Promedius!

PROS® CXR: OSTEO, has officially received regulatory approval from the MFDS (Ministry of Food and Drug Safety) as Class 2 Medical Device. Promedius’ AI-powered screening tool, PROS® CXR: OSTEO utilizes chest X-ray images to screen for osteoporosis, enabling early risk identification and enhanced clinical decision-making.

With osteoporosis-related fractures significantly impacting quality of life and increasing healthcare costs, early detection is more crucial than ever. PROS® CXR: OSTEO was also recognized as an Innovative Medical Device last November by MFDS and published in JBMR, proving its high accuracy.

We extend our heartfelt thanks to our incredible team and supporters who have been part of this journey.

We’re excited to expand its reach in both domestic and global markets. Stay tuned for more updates! 🔥

✨For more details, check out the related article here: https://bit.ly/3FEu7dG